Scientists in The Wistar Institute lab of David B. Weiner, Ph.D., have described a next-generation vaccination technology ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common ...

A breakthrough in safely delivering therapeutic DNA to cells using lipid nanoparticles could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and ...

Nanotechnology offers a next-gen solution to plant genome editing challenges by enabling precise, efficient delivery of CRISPR, RNA, and DNA tools using nanoparticles like AuNPs, CNTs, and lipid ...

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer. A new process that ...

PLC (AIM: 4BB) (“4basebio”), a company which develops and commercializes the large-scale manufacture of synthetic DNA as well as nanoparticle delivery solutions, today announced that it has received ...

A collaborative effort between The Wistar Institute, University of Pennsylvania, and INOVIO Pharmaceuticals has led to an ...

Framework for nanoscale material design using programmable DNA systems enables precise control over structure, function, and immune signaling in soft materials. (Nanowerk Spotlight) Nucleic acids ...

Another company looking to initiate clinical trials with an epigenetic-editor-based treatment for hepatitis is nChroma Bio.

A breakthrough in safely delivering therapeutic DNA to cells could transform treatment for millions suffering from common chronic diseases like heart disease, diabetes, and cancer.